Title:
PHARMACEUTICAL COMBINATION AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/051725
Kind Code:
A1
Abstract:
A pharmaceutical combination and use thereof. The pharmaceutical combination comprises a substance X and a substance Y. When endocrine therapy is used in combination with CDK4/6 inhibitors to treat a breast cancer that has drug resistance, the pharmaceutical combination has a better therapeutic effect in combination with a first therapeutic agent and Fulvestrant.
Inventors:
LI YONGGUO (CN)
WEI WEI (CN)
YE WEI (CN)
WEI WEI (CN)
YE WEI (CN)
Application Number:
PCT/CN2022/122744
Publication Date:
April 06, 2023
Filing Date:
September 29, 2022
Export Citation:
Assignee:
GUANGZHOU JOYO PHARMATECH CO LTD (CN)
SHANGHAI JIA TAN PHARMATECH CO LTD (CN)
SHANGHAI JIA TAN PHARMATECH CO LTD (CN)
International Classes:
A61K45/06; A61K31/519; A61K31/5685; A61P35/00
Domestic Patent References:
| WO2020076432A1 | 2020-04-16 | |||
| WO2021180111A1 | 2021-09-16 | |||
| WO2017101829A1 | 2017-06-22 | |||
| WO2021113219A1 | 2021-06-10 | |||
| WO2021174195A2 | 2021-09-02 |
Foreign References:
| CN106456776A | 2017-02-22 |
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF:
Previous Patent: SMART GLASSES
Next Patent: CURABLE RESIN COMPOSITION, LAMINATE, CURED PRODUCT, AND ELECTRONIC COMPONENT
Next Patent: CURABLE RESIN COMPOSITION, LAMINATE, CURED PRODUCT, AND ELECTRONIC COMPONENT